cigna and glp 1 meds will stop covering GLP-1 weight-loss drugs including Wegovy Zepbound in its ​employee health plan effective July 1, according to Reuters Cigna reaches new deal on

Here's the current landscape: Brand Name Oral Semaglutide (Wegovy pill): Novo Nordisk announced a limited-time price of $149/month for the starting dose Higher doses (25mg) may cost more Launched in January 2026 Additional costs may apply such as labs, consultations, shipping and membership Brand Name Injectable GLP-1s: Wegovy: $1,000-1,500/month without insurance Ozempic: $900-1,000/month without insurance Mounjaro/Zepbound: $1,000-1,400/month without insurance Compounded Injectable GLP-1s: Affinity Whole Health: Starting at $299/month for compounded semaglutide Includes medications, supplies, shipping, and ongoing support Significant savings compared to brand names Compounded ODT Formulations: Prices vary widely, typically $299-449/month for compounded semaglutide or tirzepatide ODTs Generally more expensive than compounded injectables Available through compounding pharmacies Currently, compounded injectable medications from FDA-registered facilities remain the most cost-effective option for most patients seeking GLP-1 therapy

Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism

Excessive MMP activity can lead to the weakening of fibrous caps and increase the risk of plaque rupture in atherosclerotic lesions

Ozempic is not approved for use as a weight loss treatment, for diabetes prevention, or to treat Type 1 diabetes or metabolic syndrome (without a co-diagnosis of Type 2 diabetes)

GLP-1 Success Shouldnt Mean Losing Lean Muscle